BUY Alkem Laboratories Limited — Elara Capital
byElara CapitalHorizon: NA (inferred 1 year)28 Aug 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·4 Sept · 2d ago
Elara initiates coverage on Alkem, Eris, IPCA and Mankind. Check ratings and targets
NewsEt-Markets·28 Aug · 1w ago
2 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·17 Aug · 3w ago
Alkem Labs Q1 Results: Shares down 3% after profit falls; revenue rises 11%
NewsCnbc-Tv18·14 Aug · 3w ago
Four midcap stocks near 52-week highs that still look cheap
NewsLivemint·11 Aug · 4w ago
Broker’s Call: Alkem Laboratories (Buy)
NewsHbl·1 Sept · 4d ago
Buy, Sell Or Hold: Ola Electric, Gillette India, Vedanta, Paytm, Ashok Leyland, Alkem Laboratories — Ask Profit
NewsNdtv-Profit·21 Aug · 2w ago
Five reasons behind Investec's upgrade of Alkem Labs, and why JPMorgan is cautious
NewsCnbc-Tv18·17 Aug · 3w ago
Alkem Laboratories Limited announced the outcome of its Board Meeting held on August 14, 2026. The board approved the standalone and consolidated unaudited financial results for the quarter ended June
NSE · Outcome of Board Meeting·14 Aug · 3w ago
2 other SEBI-registered advisors have active long-term SELL calls on this stock
Advisor consensus · same horizon·17 Aug · 3w ago
Alkem Laboratories Q1 Result: Net Profit Drops 22% Despite Revenue Growth
NewsNdtv-Profit·14 Aug · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.